Skip to main content
. 2013 Oct 15;109(11):2886–2893. doi: 10.1038/bjc.2013.614

Table 4. Eligible haematopoietic malignancies and case counts and rates (per 100 000 PY) by selected factors.

  Leukaemia
 
 
 
Total
Without CLL
Hodgkins disease
Non-Hodgkins lymphoma
Multiple myeloma
 
Category Cases Rate Cases Rate Cases Rate Cases Rate Cases Rate Person-years
Sex
Male 45 13.2 31 9.1 7 2 13 3.8 4 1.2 341 721
Female
54
10.7
41
8.1
11
2.2
23
4.5
13
2.6
506 157
Ethnicity
Slav 68 10.6 46 7.2 14 2.2 27 4.2 12 1.9 643 226
Tartar/Bashkir
31
15.1
26
12.7
4
2
9
4.4
5
2.4
204 652
Age at entry
0–9 17 9.3 12 6.5 2 1.1 3 1.6 2 1.1 183 294
10–19 26 11.7 24 10.8 3 1.3 15 6.7 5 2.2 223 005
20–39 33 10.9 20 6.6 9 3 15 5 9 3 301 928
40+
23
17.7
16
12.3
4
3.1
3
2.3
1
0.8
129 650
Years since entry
<5 5 0.7 5 0.7 1 0.1 0 0.0 0 0.0 68 813
5–9 6 0.5 5 0.4 3 0.3 4 0.3 0 0.0 119 385
10–19 23 1.1 18 0.9 3 0.1 1 0.0 2 0.1 207 261
20–29 19 1.1 15 0.9 3 0.2 7 0.4 0 0.0 172 133
30–39 12 0.9 5 0.4 5 0.4 8 0.6 5 0.4 134 104
40+
34
2.3
24
1.6
3
0.2
16
1.1
10
0.7
146 181
Attained age
0–19 7 0.9 7 0.9 1 0.1 0 0.0 0 0.0 73 929
20–39 9 5.2 9 5.2 4 1.6 2 0.6 0 0 234 879
40–59 28 9 22 7 4 1.3 16 5.1 6 1.9 312 652
60–74 46 26.9 27 15.8 9 5.3 16 9.4 9 5.3 170 751
75+
9
16.2
7
12.6
0
0
2
3.6
2
3.6
55 667
Bone marrow dose (Gy)
<0.01 12 12 6 6 3 3 4 4 0 0 100 034
0.01–0.5 6 5.9 2 2 3 2.9 2 2 0 0 102 300
0.5–0.1 5 9.1 4 7.3 1 1.8 5 9.1 2 3.6 55 078
0.1–0.15 4 6.8 3 5.1 0 0 4 6.8 2 3.4 58 992
0.15–0.3 16 10.7 10 6.7 4 2.7 5 3.3 3 2 149 934
0.3–0.5 13 10.6 10 8.2 2 1.6 3 2.5 3 2.5 122 393
0.5–1 22 14.4 20 13.1 2 1.3 8 5.2 5 3.3 152 752
1+
21
19.7
17
16
3
2.8
5
4.7
2
1.9
106 394
Total 99 11.7 72 8.5 18 2.1 36 4.2 17 2 847 877